Foxp3 and Toll-like receptor signaling balance T reg cell anabolic metabolism for suppression

CD4 effector T cells (T cells) and regulatory T cells (T cells) undergo metabolic reprogramming to support proliferation and immunological function. Although signaling via the lipid kinase PI(3)K (phosphatidylinositol-3-OH kinase), the serine-threonine kinase Akt and the metabolic checkpoint kinase...

Full description

Saved in:
Bibliographic Details
Published inNature immunology Vol. 17; no. 12; p. 1459
Main Authors Gerriets, Valerie A, Kishton, Rigel J, Johnson, Marc O, Cohen, Sivan, Siska, Peter J, Nichols, Amanda G, Warmoes, Marc O, de Cubas, Aguirre A, MacIver, Nancie J, Locasale, Jason W, Turka, Laurence A, Wells, Andrew D, Rathmell, Jeffrey C
Format Journal Article
LanguageEnglish
Published United States 01.12.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:CD4 effector T cells (T cells) and regulatory T cells (T cells) undergo metabolic reprogramming to support proliferation and immunological function. Although signaling via the lipid kinase PI(3)K (phosphatidylinositol-3-OH kinase), the serine-threonine kinase Akt and the metabolic checkpoint kinase complex mTORC1 induces both expression of the glucose transporter Glut1 and aerobic glycolysis for T cell proliferation and inflammatory function, the mechanisms that regulate T cell metabolism and function remain unclear. We found that Toll-like receptor (TLR) signals that promote T cell proliferation increased PI(3)K-Akt-mTORC1 signaling, glycolysis and expression of Glut1. However, TLR-induced mTORC1 signaling also impaired T cell suppressive capacity. Conversely, the transcription factor Foxp3 opposed PI(3)K-Akt-mTORC1 signaling to diminish glycolysis and anabolic metabolism while increasing oxidative and catabolic metabolism. Notably, Glut1 expression was sufficient to increase the number of T cells, but it reduced their suppressive capacity and Foxp3 expression. Thus, inflammatory signals and Foxp3 balance mTORC1 signaling and glucose metabolism to control the proliferation and suppressive function of T cells.
ISSN:1529-2916
DOI:10.1038/ni.3577